TRAVERE THERAPEUTICS INC
TVTXNASDAQ🏆 #1161 by market capEarnings Oct 28US Equity
$62.16▲ $2.01 (+3.24%)
🌙 After hours$62.79▲ 1.01%Regular close · extended-hours price shown1h—
24h▲ 3.2%
7d▼ 0.5%
14d▲ 8.5%
30d▲ 8.9%
1y▲ 244.2%
🏦Market Cap
$5.78B
Small Cap
📈Revenue Growth (YoY)
+110.5%
High Growth
📊Gross Margin
94.4%
High
💵FCF Margin
8.7%
Moderate
⚖️P/S Ratio
9.8x
Elevated
Otter Score
63
Fair
Earnings
Q3 · 2026Reported 2026-08-04Earnings Per Share
Actual
-0.37
Expected
-0.13
miss
−174.80%
YoY −164.30%
Revenue
Actual
$169.58M
Expected
$157.27M
beat
+7.80%
YoY +48.20%
Consensus estimates
Recent quarters
Q3 2026
-0.37
miss
Q2 2026
-0.39
miss
Q1 2026
0.03
inline
Q4 2025
0.28
beat